Global standards for cervical cancer prevention emphasize early identification of high‑risk HPV, accurate evaluation, and timely treatment.
The World Health Organization reinforces these standards by promoting efforts to reduce loss to follow‑up and expand access to care in real‑world settings.
Liger Medical develops technologies that enable providers to apply these standards within a connected screen‑triage‑treat workflow.
A clear process for identifying risk, evaluating patients, and delivering treatment
Identify patients with high-risk HPV genotypes
Evaluate patients and stratify risk for treatment
Deliver timely care when it matters most
Supporting screening, triage, and treatment in real world settings
CEO, Liger Medical
After 50 years of developing medical devices for women's healthcare, I take pride in Liger Medical's vision of providing tools aligned with the World Health Organization.
We are dedicated to supporting the global mission to eliminate Cervical Cancer.
Our focus is on minimizing death and morbidity for women in the critical age that stabilizes family society.
Complete screening, evaluation, and treatment without delay
Liger Medical's connected technologies help providers deliver cervical pre-cancer care in a single visit—from HPV screening and colposcopic evaluation to same-day treatment. By keeping patients in care when it matters most, we support efforts to reduce loss to follow-up and expand access to timely care.
